Last reviewed · How we verify
Metrazone (FEPRAZONE)
At a glance
| Generic name | FEPRAZONE |
|---|---|
| Drug class | feprazone |
| Modality | Small molecule |
| Therapeutic area | Pain |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Mental Practice Combined With Physical Practice to Improve the Gait Performance of People With Parkinson's Disease (NA)
- Protocol: Mental Practice Combined With Physical Practice of Gait in Parkinson's Disease. (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Metrazone CI brief — competitive landscape report
- Metrazone updates RSS · CI watch RSS